Late sarcoma development after curettage and bone grafting of benign bone tumors
Open accessAbstract
Background and aim Rarely sarcomas develop in previous benign lesions, after a long term disease free interval. We report the experience on these rare cases observed at a single Institution.Patients and methods 12 cases curetted and grafted, without radiotherapy developed sarcomas, between 1970 and 2005, 6.5-28 years from curettage (median 18, average 19). Age ranged from 13 to 55 years (median 30, average 32) at first diagnosis; tumors were located in the extremities (9 GCT, benign fibrous histiocytoma, ABC, and solitary bone cyst). Radiographic and clinic documentation, for the benign and malignant lesions, were available. Histology was available for 7 benign and all malignant lesions.Results To fill cavities, autogenous bone was used in 4 cases, allograft in 2, allograft and tricalcium-phosphate/hydroxyapatite in 1, autogenous/allograft in 1, heterogenous in 1. For 3 cases the origin was not reported. Secondary sarcomas, all high grade, were 8 osteosarcoma, 3 malignant fibrous histiocytoma, and 1 fibrosarcoma.Conclusions Recurrences with progression from benign tumors are possible, but the very long intervals here reported suggest a different cancerogenesis for these sarcomas. This condition is extremely rare accounting for only 0.26% of all malignant bone sarcomas treated in the years 1970-2005 and represents only 8.76% of all secondary bone sarcomas treated in the same years. This incidence is the same as that of sarcomas arising on fibrous dysplasia, and is lower than those arising on bone infarcts or on Paget's disease. This possible event must be considered during follow-up of benign lesions.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Whether benign bone tumours trigger osteosarcoma transformation through accumulation of genetic and epigenetic events or through creation of a permissive environment remains unclear.
“Whether these benign bone tumours trigger a transformation based on the accumulation of genetic and epigenetic events or the creation of an environment permissive to malignant transformation remains unclear 28 .”
From Osteosarcoma (2022) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 40 · Cited by 28
Research works printed but not linked: 4
- Brindley JW, Greene JF, Frankel LS. Malignant transformation of aneurysmal bone cyst. Clin Orthop 2005;438:282-7.
- Huvos AG, Butler A, Bretsky SS. Osteogenic sarcoma associated with Paget's disease of bone. A clinicopathologic study of 65 patients. Cancer 1983;52:1489- 95.
- Johnson LC, Vetter M, Putschar WGJ. Sarcoma arising in bone cyst. Virchows Arch Pathol Anat Physiol Klin Med 1962;335:428-51.
- Torres FX, Kyriakos M. Bone infarct-associated osteosarcoma. Cancer 1992;70:2418-30.
- Authors
- Picci, P., Sieberova, G., Alberghini, M., Balladelli, A., Vanel, D., Hogendoorn, P. C. W., & Mercuri, M.
- Affiliations
- Istituto Ortopedico Rizzoli (IT)
- Leiden University Medical Center (NL)
- Corresponding author
- Picci, Piero
- Venue
- European Journal of Radiology
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 77
- Issue
- 1
- Pages
- 19-25
- ISSN
- 0720-048X (ISSN-L)
- OpenAlex
- W2128869883
- Cited by
- 28
- References
- 40
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 4 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 3 · 2015: 1 · 2014: 1 · 2013: 3 · 2012: 2
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Radiology (publishedVersion)
- PubMed (publishedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Commission
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoma Diagnosis and Treatment
- Health Sciences › Medicine › Rheumatology › Bone Tumor Diagnosis and Treatments
- Health Sciences › Dentistry › Oral Surgery › Oral and Maxillofacial Pathology
- Keywords
- benign bone tumor, curettage, bone grafting, osteosarcoma, malignant fibrous histiocytoma, fibrosarcoma, giant cell tumor of bone, dermatofibroma, aneurysmal bone cyst, solitary bone cyst, long-term follow-up, cancerogenesis, autologous bone graft, allograft
- MeSH terms
- Adolescent, Adult, Bone Neoplasms, Curettage, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Radiography, Sarcoma, Bone Transplantation, Neoplasms, Second Primary, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review